Search Results - qianghua xia

1 Results Sort By:
Repurpose PARP-1 Inhibitors for Type 2 Diabetes and Cystic Fibrosis Related Diabetes
Expand to Two Additional Indications for Existing DrugMarket NeedCurrent therapies for type 2 diabetes (T2D), including the closely similar cystic fibrosis related diabetes (CFRD), only address the symptoms, not the underlying pathophysiology of the disease. So instead of halting disease progression, the growing number of patients continue to have ...
Published: 5/10/2017   |   Inventor(s): Qianghua Xia, Struan Grant
Keywords(s): Cystic Fibrosis, Diabetes
Category(s): Therapeutic